Search results
Showing 31 to 32 of 32 results for obinutuzumab
Managed access allows people to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.
More than 1,000 people each year will benefit from NICE's recommendation.